Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 

The global Meloxicam Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Meloxicam Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Meloxicam Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Meloxicam Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Meloxicam Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablet
Capsule

Segment by Application
Osteoarthritis in adults (OA)
Rheumatoid Arthritis in adults (RA)
Pediatric patients